Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC)-Reference-Cited by-同舟云学术

Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC)

Published:2021-01-08 Issue:18 Volume:27 Page:5038-5048
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Chen Helen X.,Song Minkyung,Maecker Holden T.,Gnjatic Sacha^ORCID,Patton David^ORCID,Lee J. Jack^ORCID,Adam Stacey J.,Moravec Radim,Liu Xiaole Shirley,Cerami Ethan,Lindsay James^ORCID,Tang Ming,Hodi F. Stephen,Wu Catherine J.^ORCID,Wistuba Ignacio I.,Al-Atrash Gheath,Bernatchez Chantale^ORCID,Bendall Sean C.^ORCID,Hewitt Stephen M.,Sharon Elad^ORCID,Streicher Howard,Enos Rebecca A.^ORCID,Bowman Melissa D.,Tatard-Leitman Valerie M.,Sanchez-Espiridion Beatriz,Ranasinghe Srinika,Pichavant Mina,Del Valle Diane M.,Yu Joyce,Janssens Sylvie,Peterson-Klaus Jenny,Rowe Cathy,Bongers Gerold^ORCID,Jenq Robert R.,Chang Chia-Chi^ORCID,Abrams Jeffrey S.^ORCID,Mooney Margaret^ORCID,Doroshow James H.,Harris Lyndsay N.,Thurin Magdalena

Funder

G Bongers of the Icahn School of Medicine at Mount Sinai CIMAC

Dana-Farber Cancer Institute

CIMAC

MD Anderson Cancer Center

Stanford University

CTIMS

LLC

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma;Cancer Research Communications;2024-07-01

2. Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours;Nature Reviews Cancer;2024-06-12

3. New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication;MedComm;2024-05-23

4. SITC Clinical Immuno-Oncology Network (SCION) commentary on measurement and interpretation of essential biomarkers in early clinical trials;Journal for ImmunoTherapy of Cancer;2024-03

5. Correction: SITC clinical Immuno-Oncology network (SCION) commentary on measurement and interpretation of essential biomarkers in early clinical trials;Journal for ImmunoTherapy of Cancer;2024-03